Tofacitinib and Iguratimod Combination Shows Promise in PPF Tofacitinib and iguratimod show dual efficacy in controlling synovitis and pulmonary fibrosis, according to a new study.

#Tofacitinib combined with #Iguratimod shows dual efficacy in controlling #Synovitis and #LungFibrosis. Study in Frontiers in Immunology.

Read more: https://bit.ly/4tqBIkB

#RareDisease #Immunology #ProgressivePulmonaryFibrosis